Triple therapy aims to melt artery plaque before first heart attack
NCT ID NCT07474649
First seen Mar 26, 2026 · Last updated May 13, 2026 · Updated 7 times
Summary
This study tests whether a combination of three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and a high-intensity statin) can reduce and stabilize plaque buildup in the coronary arteries. It includes 103 adults with early atherosclerosis who have never had a heart attack or stroke and are not on any cholesterol drugs. Participants will receive the triple therapy and have their plaque changes measured over time using imaging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.